As the 2020 campaign kicks off, Democrats scramble to prove their leadership on lowering drug costs
WASHINGTON — As they jostle to position themselves for 2020, many Democratic presidential hopefuls have suddenly zeroed in on a narrow policy target: prescription drug prices.
Sen. Bernie Sanders called his first press conference since the midterms not to discuss President Trump’s quest for a wall or tout universalized health coverage, but to unveil a proposal to lower drug prices that mirrors one of Trump’s own. Sen. Cory Booker dialed up his own rhetoric to campaign-trail levels, decrying high drug prices as “a stain on the very idea of America.” The House Oversight Committee, too, set drug prices atop its own agenda, scheduling a hearing on that issue that will occur more than a week before it calls former Trump lawyer Michael Cohen to testify.
In the Senate, no fewer than six Democrats — including five of the men and women most likely to follow Sen. Elizabeth Warren
